Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

HLA class II restricted T-cell receptor gene transfer generates CD4+ T cells with helper activity as well as cytotoxic capacity

Gene Therapy volume 12, pages 1686–1695 (2005)Cite this article

Abstract

Both cytotoxic T cells and helper T cells are important in immune responses against pathogens and malignant cells. In hematological malignancies which express HLA class II molecules, immunotherapy may be directed to HLA class II restricted antigens. We investigated whether it is possible to engineer HLA class II restricted T cells with both antigen-specific cytolytic activity and the capacity to produce high amounts of cytokines. CD4+ and CD8+ peripheral-blood-derived T cells were retrovirally transduced with the HLA class II restricted minor histocompatibility antigen dead box RNA helicase Y (DBY)-specific TCR. The TCR-transduced CD4+ T cells exerted DBY-specific cytolytic activity, produced Th0, Th1, or Th2 cytokines, and proliferated upon DBY-specific stimulation. TCR-transduced CD8+ T cells exerted cytolytic activity which equaled the level of cytolytic activity of the TCR-transferred CD4+ T cells. Cotransfer of CD4 enhanced the cytolytic activity of the TCR-transduced CD8+ T cells, but introduction of CD4 was not sufficient to generate DBY-specific CD8+ T cells with the capacity to produce high amounts of cytokines. In this study, we demonstrated the feasibility to engineer T cells with antigen-specific cytolytic activity, as well as the ability to produce significant amounts of cytokines, by TCR transfer to CD4+ T cells.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

References

  1. Kolb HJ et al. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 1990; 76: 2462–2465.

    CAS  PubMed  Google Scholar 

  2. Kolb HJ et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia. Blood 1995; 86: 2041–2050.

    CAS  PubMed  Google Scholar 

  3. Collins Jr RH et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol 1997; 15: 433–444.

    Article  PubMed  Google Scholar 

  4. Porter DL et al. Treatment of relapsed leukemia after unrelated donor marrow transplantation with unrelated donor leukocyte infusions. Blood 2000; 95: 1214–1221.

    CAS  PubMed  Google Scholar 

  5. Zorn E et al. Infusion of CD4+ donor lymphocytes induces the expansion of CD8+ donor T cells with cytolytic activity directed against recipient hematopoietic cells. Clin Cancer Res 2002; 8: 2052–2060.

    CAS  PubMed  Google Scholar 

  6. Soiffer RJ et al. Randomized trial of CD8+ T-cell depletion in the prevention of graft-versus-host disease associated with donor lymphocyte infusion. Biol Blood Marrow Transplant 2002; 8: 625–632.

    Article  PubMed  Google Scholar 

  7. Shimoni A et al. Long-term follow-up of recipients of CD8-depleted donor lymphocyte infusions for the treatment of chronic myelogenous leukemia relapsing after allogeneic progenitor cell transplantation. Biol Blood Marrow Transplant 2001; 7: 568–575.

    Article  CAS  PubMed  Google Scholar 

  8. Alyea E et al. T-cell-depleted allogeneic bone marrow transplantation followed by donor lymphocyte infusion in patients with multiple myeloma: induction of graft-versus-myeloma effect. Blood 2001; 98: 934–939.

    Article  CAS  PubMed  Google Scholar 

  9. Alyea EP et al. Toxicity and efficacy of defined doses of CD4(+) donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant. Blood 1998; 91: 3671–3680.

    CAS  PubMed  Google Scholar 

  10. Giralt S et al. CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation. Blood 1995; 86: 4337–4343.

    CAS  PubMed  Google Scholar 

  11. Spierings E et al. Identification of HLA class II-restricted H–Y-specific T-helper epitope evoking CD4+ T-helper cells in H–Y-mismatched transplantation. Lancet 2003; 362: 610–615.

    Article  CAS  PubMed  Google Scholar 

  12. Faber LM et al. Generation of CD4+ cytotoxic T-lymphocyte clones from a patient with severe graft-versus-host disease after allogeneic bone marrow transplantation: implications for graft-versus-leukemia reactivity. Blood 1995; 86: 2821–2828.

    CAS  PubMed  Google Scholar 

  13. Faber LM, Luxemburg-Heijs SA, Willemze R, Falkenburg JH . Generation of leukemia-reactive cytotoxic T lymphocyte clones from the HLA-identical bone marrow donor of a patient with leukemia. J Exp Med 1992; 176: 1283–1289.

    Article  CAS  PubMed  Google Scholar 

  14. Falkenburg JH et al. Complete remission of accelerated phase chronic myeloid leukemia by treatment with leukemia-reactive cytotoxic T lymphocytes. Blood 1999; 94: 1201–1208.

    CAS  PubMed  Google Scholar 

  15. Clay TM et al. Efficient transfer of a tumor antigen-reactive TCR to human peripheral blood lymphocytes confers anti-tumor reactivity. J Immunol 1999; 163: 507–513.

    CAS  PubMed  Google Scholar 

  16. Cooper LJ et al. Transfer of specificity for human immunodeficiency virus type 1 into primary human T lymphocytes by introduction of T-cell receptor genes. J Virol 2000; 74: 8207–8212.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Stanislawski T et al. Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer. Nat Immunol 2001; 2: 962–970.

    Article  CAS  PubMed  Google Scholar 

  18. Heemskerk MH et al. Redirection of antileukemic reactivity of peripheral T lymphocytes using gene transfer of minor histocompatibility antigen HA-2-specific T-cell receptor complexes expressing a conserved alpha joining region. Blood 2003; 102: 3530–3540.

    Article  CAS  PubMed  Google Scholar 

  19. Heemskerk MH et al. Reprogramming of virus-specific T cells into leukemia-reactive T cells using T-cell receptor gene transfer. J Exp Med 2004; 199: 885–894.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Schumacher TN . T-cell-receptor gene therapy. Nat Rev Immunol 2002; 2: 512–519.

    Article  CAS  PubMed  Google Scholar 

  21. Heemskerk MH et al. Dual HLA class I and class II restricted recognition of alloreactive T lymphocytes mediated by a single T-cell receptor complex. Proc Natl Acad Sci USA 2001; 98: 6806–6811.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Fujio K et al. Functional reconstitution of class II MHC-restricted T cell immunity mediated by retroviral transfer of the alpha beta TCR complex. J Immunol 2000; 165: 528–532.

    Article  CAS  PubMed  Google Scholar 

  23. Chamoto K et al. Potentiation of tumor eradication by adoptive immunotherapy with T-cell receptor gene-transduced T-helper type 1 cells. Cancer Res 2004; 64: 386–390.

    Article  CAS  PubMed  Google Scholar 

  24. Sun JC, Bevan MJ . Defective CD8 T-cell memory following acute infection without CD4 T cell help. Science 2003; 300: 339–342.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Gamadia LE et al. Primary immune responses to human CMV: a critical role for IFN-gamma-producing CD4+ T cells in protection against CMV disease. Blood 2003; 101: 2686–2692.

    Article  CAS  PubMed  Google Scholar 

  26. Shedlock DJ, Shen H . Requirement for CD4 T cell help in generating functional CD8 T-cell memory. Science 2003; 300: 337–339.

    Article  CAS  PubMed  Google Scholar 

  27. Bourgeois C, Rocha B, Tanchot C . A role for CD40 expression on CD8+ T cells in the generation of CD8+ T-cell memory. Science 2002; 297: 2060–2063.

    Article  CAS  PubMed  Google Scholar 

  28. Vogt MH et al. The DBY gene codes for an HLA-DQ5-restricted human male-specific minor histocompatibility antigen involved in graft-versus-host disease. Blood 2002; 99: 3027–3032.

    Article  CAS  PubMed  Google Scholar 

  29. Arden B, Clark SP, Kabelitz D, Mak TW . Human T-cell receptor variable gene segment families. Immunogenetics 1995; 42: 455–500.

    CAS  PubMed  Google Scholar 

  30. Doyle C, Strominger JL . Interaction between CD4 and class II MHC molecules mediates cell adhesion. Nature 1987; 330: 256–259.

    Article  CAS  PubMed  Google Scholar 

  31. Irvine DJ, Purbhoo MA, Krogsgaard M, Davis MM . Direct observation of ligand recognition by T cells. Nature 2002; 419: 845–849.

    Article  CAS  PubMed  Google Scholar 

  32. Kessels HW, Wolkers MC, Schumacher TN . Adoptive transfer of T-cell immunity. Trends Immunol 2002; 23: 264–269.

    Article  CAS  PubMed  Google Scholar 

  33. Becker C et al. Adoptive tumor therapy with T lymphocytes enriched through an IFN-gamma capture assay. Nat Med 2001; 7: 1159–1162.

    Article  CAS  PubMed  Google Scholar 

  34. Dunbar PR et al. A shift in the phenotype of melan-A-specific CTL identifies melanoma patients with an active tumor-specific immune response. J Immunol 2000; 165: 6644–6652.

    Article  CAS  PubMed  Google Scholar 

  35. Valmori D et al. Circulating tumor-reactive CD8(+) T cells in melanoma patients contain a CD45RA(+)CCR7(−) effector subset exerting ex vivo tumor-specific cytolytic activity. Cancer Res 2002; 62: 1743–1750.

    CAS  PubMed  Google Scholar 

  36. Kloosterboer FM et al. Direct cloning of leukemia-reactive T cells from patients treated with donor lymphocyte infusion shows a relative dominance of hematopoiesis-restricted minor histocompatibility antigen HA-1 and HA-2 specific T cells. Leukemia 2004; 18: 798–808.

    Article  CAS  PubMed  Google Scholar 

  37. Fowler DH, Gress RE . Th2 and Tc2 cells in the regulation of GVHD, GVL, and graft rejection: considerations for the allogeneic transplantation therapy of leukemia and lymphoma. Leuk Lymphoma 2000; 38: 221–234.

    Article  CAS  PubMed  Google Scholar 

  38. Fowler DH, Bishop MR, Gress RE . Immunoablative reduced-intensity stem cell transplantation: potential role of donor Th2 and Tc2 cells. Semin Oncol 2004; 31: 56–67.

    Article  CAS  PubMed  Google Scholar 

  39. Fowler DH et al. Cells of Th2 cytokine phenotype prevent LPS-induced lethality during murine graft-versus-host reaction. Regulation of cytokines and CD8+ lymphoid engraftment. J Immunol 1994; 152: 1004–1013.

    CAS  PubMed  Google Scholar 

  40. Orsini E et al. Expansion of tumor-specific CD8+ T-cell clones in patients with relapsed myeloma after donor lymphocyte infusion. Cancer Res 2003; 63: 2561–2568.

    CAS  PubMed  Google Scholar 

  41. Montagna D et al. Ex vivo generation and expansion of anti-tumor cytotoxic T-cell lines derived from patients or their HLA-identical sibling. Int J Cancer 2004; 110: 76–86.

    Article  CAS  PubMed  Google Scholar 

  42. Falkenburg JH, van de Corput L, Marijt EW, Willemze R . Minor histocompatibility antigens in human stem cell transplantation. Exp Hematol 2003; 31: 743–751.

    Article  CAS  PubMed  Google Scholar 

  43. Falkenburg JH et al. Polymorphic and monomorphic HLA-DR determinants on human hematopoietic progenitor cells. Blood 1984; 63: 1125–1132.

    CAS  PubMed  Google Scholar 

  44. Nunez G et al. Expression of HLA-DR, MB, MT and SB antigens on human mononuclear cells: identification of two phenotypically distinct monocyte populations. J Immunol 1984; 133: 1300–1306.

    CAS  PubMed  Google Scholar 

  45. Brouwer RE et al. Expression and induction of costimulatory and adhesion molecules on acute myeloid leukemic cells: implications for adoptive immunotherapy. Exp Hematol 2000; 28: 161–168.

    Article  CAS  PubMed  Google Scholar 

  46. Navarrete C, Fernandez N, Alonso MC, Festenstein H . Ontogenic and functional implications of the differential expression of HLA-DQ antigens on leukemic cells. Hum Immunol 1986; 16: 52–68.

    Article  CAS  PubMed  Google Scholar 

  47. Cannistra SA, Daley JF, Larcom P, Griffin JD . Expression of Ia antigens on myeloid progenitor cells in chronic myeloid leukemia: direct analysis using partially purified colony-forming cells. Blood 1985; 65: 414–422.

    CAS  PubMed  Google Scholar 

  48. Orgad S et al. Expression of HLA-DR alloantigens on acute lymphoblastic leukemia lymphoblasts. Hum Immunol 1984; 9: 67–74.

    Article  CAS  PubMed  Google Scholar 

  49. Al Katib A, Koziner B . Leu-10 (HLA-DC/DS) antigen distribution in human leukaemic disorders as detected by a monoclonal antibody: correlation with HLA-DR expression. Br J Haematol 1984; 57: 373–382.

    Article  CAS  PubMed  Google Scholar 

  50. San Miguel JF et al. Immunophenotypic heterogeneity of multiple myeloma: influence on the biology and clinical course of the disease. Castellano-Leones (Spain) Cooperative Group for the Study of Monoclonal Gammopathies. Br J Haematol 1991; 77: 185–190.

    Article  CAS  PubMed  Google Scholar 

  51. Heemskerk MH et al. Inhibition of T cell and promotion of natural killer cell development by the dominant negative helix loop helix factor Id3. J Exp Med 1997; 186: 1597–1602.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Ruggieri L et al. Cell-surface marking of CD(34+)-restricted phenotypes of human hematopoietic progenitor cells by retrovirus-mediated gene transfer. Hum Gene Ther 1997; 8: 1611–1623.

    Article  CAS  PubMed  Google Scholar 

  53. Kinsella TM, Nolan GP . Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. Hum Gene Ther 1996; 7: 1405–1413.

    Article  CAS  PubMed  Google Scholar 

  54. Wu TC et al. Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens. Proc Natl Acad Sci USA 1995; 92: 11671–11675.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Hanenberg H et al. Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells. Nat Med 1996; 2: 876–882.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Reinier van der Linden and Maarten van de Keur for expert technical assistance. Renate Hagedoorn is acknowledged for her help with PCR primer design and PCR optimalization. This study was supported by grant 2001-2490 from the Dutch Cancer Society.

Author information

Authors and Affiliations

  1. Department of Hematology, Laboratory of Experimental Hematology, Leiden University Medical Center, Leiden, The Netherlands

    L T van der Veken, M Hoogeboom, R A de Paus, R Willemze, J H F Falkenburg & M H M Heemskerk

Authors
  1. L T van der Veken
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M Hoogeboom
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R A de Paus
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R Willemze
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J H F Falkenburg
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M H M Heemskerk
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

van der Veken, L., Hoogeboom, M., de Paus, R. et al. HLA class II restricted T-cell receptor gene transfer generates CD4+ T cells with helper activity as well as cytotoxic capacity. Gene Ther 12, 1686–1695 (2005). https://doi.org/10.1038/sj.gt.3302586

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3302586

Keywords

  • cytotoxic T cells
  • Th1/Th2 cells
  • T-cell receptors
  • human

This article is cited by

Search

Advanced search

Quick links